Browse articles from EyeWorld.org related to IOLs. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
“If there was ever a top 10 list of issues on which eyecare as a whole could ‘up its game,’ it should include the fact that we all need to be more aggressive about educating patients on the fact that they can create their own self-induced keratoconus by repetitive pressure on their eyes,” according to EyeWorld Refractive Editor Vance Thompson, MD.
When choosing a refractive procedure, there is a lot of information for surgeons to go over with the patient, and the possibility of needing implant surgery in the future is one point for discussion. Three experts shared how they counsel patients, specific considerations, and how changing technology has had an impact on this and may open more options in the future.
➤ FDA grants IND for Stargardt gene therapy ➤ Phase 2 clinical trial evaluates oral nicotinamide and pyruvate effect on visual function ➤ First ophthalmic formulation of bevacizumab moves toward FDA BLA submission ➤ Positive results for faricimab as an investigational treatment for wet AMD, DME ➤ Eye scans and AI predict risk of heart attack ➤ ASCRS news and events
➤ Small-aperture IOL receives approvable letter from the FDA ➤ Topline results from Phase 2 clinical trial for intracanalicular insert for treatment of dry eye disease ➤ First in-human study to target biomarkers in the eye that identify ALS ➤ Study provides better understanding for bilateral effect after unilateral injection of gene therapy ➤ ASCRS news and events
➤ Positive topline clinical data for investigational topical presbyopia treatment ➤ FDA grants IDE for modular IOL with fluid-filled optic ➤ First participants enrolled in Phase 3 trial for mydriasis reversal ➤ Analysis: Subgroup of dry eye patients benefit from investigational treatment ➤ NDA approved for generic drug designed to treat inflammation, pain ➤ First patient enrolled in Phase 2a study for wet AMD and DME candidate ➤ ASCRS news and events
David Chang, MD, and Kendall Donaldson, MD, MS, chaired the in-person ASCRS 20/Happy in 2021 program in New Orleans, Louisiana, an expansion of the ASCRS Master Class in Refractive Cataract Surgery. The CME program included presentations on a variety of refractive topics.
➤ Spotlight on cataract complications ➤ Rock hard cataracts ➤ Dealing with halos and starbursts ➤ Handling posterior polar cataracts ➤ Non-capsular IOL fixation ➤ Advanced techniques and innovations in MSICS
➤ State of the union on laser vision correction ➤ Practical insights on MIGS ➤ Glaucoma pipeline therapies and alternative therapeutics ➤ Future of refractive cataract surgery ➤ American Glaucoma Society Subspecialty Day Lecture ➤ Presbyopia correction with refractive IOLs
➤ FDA approves suprachoroidal injection for macular edema associated with uveitis ➤ FDA approves first-of-its-kind approach to treat wet AMD ➤ Digital therapeutic for pediatric amblyopia receives FDA premarket approval ➤ Ocular insert for dry eye does not meet Phase 2 primary endpoint ➤ Study: Prozac as a possible treatment for AMD ➤ ASCRS news and events
Andres Parra, MD, Stein Eye Institute, University of California, Los Angeles, reviewed “Repositioning surgery of different intraocular lens designs in eyes with late in-the-bag intraocular lens dislocation” from the September edition of the ASCRS Journal Club.
Get the latest ophthalmology news delivered to your inbox every Friday.